Evidence map›Paper›PMID 38197890›Full record

ArticleWorld journal of urology2024

Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.

Chen-Ya Chen, Chao-Hsiang Chang, Chi-Rei Yang, Kun-Lin Hsieh, Wen-Hsin Tsing, I-Hsuan Alan Chen, Jen-Tai Lin, Chao-Yuan Huang, Jian-Hua Hong, Jen-Shu Tseng and 19 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Chen-Ya ChenDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Chao-Hsiang ChangDepartment of Urology, China Medical University and Hospital, Taichung, Taiwan.
Chi-Rei YangDepartment of Urology, China Medical University Hospital, Taichung, Taiwan.
Kun-Lin HsiehDivision of Urology, Department of Surgery, Chi-Mei Medical Center, Tainan, Taiwan.
Wen-Hsin TsingDivision of Urology, Department of Surgery, Chi-Mei Medical Center, Tainan, Taiwan.
I-Hsuan Alan ChenDivision of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan.
Jen-Tai LinDivision of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan.
Chao-Yuan HuangDepartment of Urology, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Jian-Hua HongDepartment of Urology, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Jen-Shu TsengDepartment of Urology, MacKay Memorial Hospital, Taipei, Taiwan.
Wun-Rong LinDepartment of Urology, MacKay Memorial Hospital, Taipei, Taiwan.
Yao-Chou TsaiDepartment of Surgery, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Shu-Yu WuDepartment of Surgery, Taipei Tzu Chi Hospital, The Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Cheng-Huang ShenDepartment of Urology, Ditmanson Medical Foundation, Chiayi Christian Hospital, Chiayi, Taiwan.
Ian-Seng CheongDepartment of Urology, Ditmanson Medical Foundation, Chiayi Christian Hospital, Chiayi, Taiwan.
Chuan-Shu ChenDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Cheng-Kuang YangDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Yuan-Hong JiangDepartment of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan.
Chung-You TsaiDivisions of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Thomas Y HsuehDivision of Urology, Department of Surgery, Taipei City Hospital Renai Branch, Taipei City, Taiwan.
Yung-Tai ChenDepartment of Urology, Taiwan Adventist Hospital, Taipei, Taiwan.
Chia-Chang WuDepartment of Urology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Shih-Hsiu LoDepartment of Urology, Taipei Medical University Hospital, Taipei Medical University, Taipei City, Taiwan.
Bing-Juin ChiangCollege of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.
Wei Yu LinDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chia-Yi, Taiwan.
Po-Hung LinDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
Ta-Yao TaiDepartment of Urology, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.
Wei-Ming LiDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hsiang-Ying LeeDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. ashum1009@hotmail.com.ORCID http://orcid.org/0000-0003-2405-4874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate predictive factors of increasing intravesical recurrence (IVR) rate in patients with upper tract urothelial carcinoma (UTUC) after receiving radical nephroureterectomy (RNUx) with bladder cuff excision (BCE). MATERIALS AND

methodsA total of 2114 patients were included from the updated data of the Taiwan UTUC Collaboration Group. It was divided into two groups: IVR-free and IVR after RNUx, with 1527 and 587 patients, respectively. To determine the factors affecting IVR, TNM stage, the usage of pre-operative ureteroscopy, and pathological outcomes were evaluated. The Kaplan-Meier estimator was used to estimate the rates of prognostic outcomes in overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and bladder recurrence-free survival (BRFS), and the survival curves were compared using the stratified log-rank test.

resultsBased on our research, ureter tumor, female, smoking history, age (< 70 years old), multifocal tumor, history of bladder cancer were determined to increase the risk of IVR after univariate analysis. The multivariable analysis revealed that female (BRFS for male: HR 0.566, 95% CI 0.469-0.681, p < 0.001), ureter tumor (BRFS: HR 1.359, 95% CI 1.133-1.631, p = 0.001), multifocal (BRFS: HR 1.200, 95% CI 1.001-1.439, p = 0.049), history of bladder cancer (BRFS: HR 1.480, 95% CI 1.118-1.959, p = 0.006) were the prognostic factors for IVR. Patients who ever received ureterorenoscopy (URS) did not increase the risk of IVR.

conclusionPatients with ureter tumor and previous bladder UC history are important factors to increase the risk of IVR after RNUx. Pre-operative URS manipulation is not associated with higher risk of IVR and diagnostic URS is feasible especially for insufficient information of image study. More frequent surveillance regimen may be needed for these patients.

Indexed as

Carcinoma, Transitional CellUreteral NeoplasmsUrinary Bladder NeoplasmsAgedFemaleHumansMaleNephroureterectomyPrognosisIntravesicalNephroureterectomyRecurrenceUrothelial carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.